Walleye Capital LLC Phibro Animal Health Corp Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$10.63 - $13.68 $54,340 - $69,932	-5,112 Reduced 24.6%	15,666 $202,000
Q4 2023 Feb 14, 2024	BUY	$9.59 - $12.91 $199,261 - $268,243	20,778 New	20,778 $240,000
Q4 2022 Feb 14, 2023	SELL	$12.05 - $15.14 $859,068 - $1.08 Million	-71,292 Reduced 71.37%	28,597 $383,000
Q3 2022 Nov 14, 2022	BUY	$12.82 - $20.22 $458,379 - $722,966	35,755 Added 55.75%	99,889 $1.33 Million
Q2 2022 Aug 08, 2022	BUY	$17.89 - $20.47 $532,209 - $608,962	29,749 Added 86.52%	64,134 $1.23 Million
Q1 2022 May 16, 2022	BUY	$18.39 - $21.85 $632,340 - $751,312	34,385 New	34,385 $686,000

148

20.4M

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $440M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.